Praxis Bioresearch is a biopharmaceutical company focused on the discovery and development of therapeutics for chronic neuropsychiatric.
Praxis Bioresearch has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in August 2021.
Praxis Bioresearch's investors include National Institutes of Health.
Praxis Bioresearch is headquartered in Sacramento, United States.
Praxis Bioresearch is a biopharmaceutical company focused on the discovery and development of therapeutics for chronic neuropsychiatric.
Praxis Bioresearch is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Praxis Bioresearch — Funding & Investors." VCBacked, August 5, 2021, https://www.vcbacked.co/company/praxis-bioresearch. Accessed November 15, 2026.
VCBacked. (2021). Praxis Bioresearch — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/praxis-bioresearch
{{cite web |title=Praxis Bioresearch — Funding & Investors |url=https://www.vcbacked.co/company/praxis-bioresearch |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Praxis Bioresearch? Request a listing update